The FDA has approved the first menthol e-cigarettes for sale in the US, prompting criticism from parent groups who claim the agency has "failed American families."
Tags: FDA
FDA Approves Eli Lilly's Alzheimer’s Drug Donanemab, Expanding US Treatment Options
The FDA has approved Eli Lilly’s Alzheimer’s drug donanemab, branded as Kisunla, for early symptomatic adults, providing a new treatment option for nearly 7 million Americans affected by the disease.
FDA Announces Recall of Glenmark, BluePoint Blood Pressure Capsules Over Cardiac Arrest Fear
The US Food and Drug Administration (FDA) has announced the recall of 135 batches of potassium chloride extended-release capsules due to potential risks of cardiac arrest.
Prophet Premium Blends Recalls Diamond Shruumz Edibles Due to Toxic Mushroom Chemical
Prophet Premium Blends is recalling all Diamond Shruumz edible products nationwide due to toxic levels of muscimol, a chemical found in certain mushrooms, which have caused illness in 39 people across 20 states.
US Drugmakers, Medical Device Companies Urged by FDA to Improve Diversity in Clinical Trials
The US Food and Drug Administration (FDA) urged drugmakers and medical device manufacturers to improve racial and cultural diversity in clinical trials.
Latest News
The Food and Drug Administration approved Merck’s new vaccine, Capvaxive, which was designed to protect adults from a bacteria known as pneumococcus that could cause serious illnesses like pneumonia, but is yet to face the CDC’s scrutiny.
The FDA has paused BioNTech's breast and lung cancer trial involving licensed treatment from Chinese biotech MediLink Therapeutics Ltd., citing safety concerns.
Neuroelectrics seeks FDA approval for its noninvasive head cap that uses mild electrical currents to treat brain diseases, potentially transforming care for epilepsy, depression, and Alzheimer’s.
An audit revealed that the FDA took over 15 months to act on a whistleblower complaint about conditions at an Abbott Nutrition factory.
The US FDA and DOJ have announced the formation of a task force to combat the illegal distribution and sale of electronic cigarettes, or e-cigarettes.
The Food and Drug Administration’s advisory committee endorsed Eli Lilly’s Alzheimer’s drug, donanemab, for approval to further slow the aggression of the specific type of dementia in patients despite criticisms regarding test patient deaths during clinical trials.
Abbott Laboratories announced that new FDA-cleared continuous glucose monitor sensors are available over-the-counter without a prescription.
The FDA is examining Diamond Shruumz-brand microdosing chocolate bars after eight individuals experienced symptoms including vomiting, seizures, and central nervous system depression, prompting concerns over the product's safety.
GSK has announced that the FDA has expanded the approval of its respiratory syncytial virus (RSV) vaccine, Arexvy, to those aged 50 to 59.
